As the inhibitors of the pro-inflammatory chemokine, IL-8, may be used to treat immune-associated diseases, such as IBD, we measured the LPS-stimulated expression of IL-8 by treating HT-29 cells with limonoids. The gene discussed is CXCL8; the disease is inflammatory bowel disease.